Drugs Flashcards
Acetylsalicylic Acid (Aspirin)
Functional class, MOA, Indications, Contraindications, Precautions/Warnings, Adverse Reactions, Drug Interactions, Dose/Route, Pharmacokinetics
Functional Class: Anti-platelet
MOA: Blocks production of cyclooxygenase, the precursor to Thromboxane A2. TA2 is what induces platelet aggregation. Anti-inflammatory actions contribute to analgesic effects. Reduces fever by causing peripheral vasodilation and sweating.
Indications: CP, ACS, Acute MI
Contraindications: Hypersensitivity to NSAIDs
Precautions/Warnings: Peptic ulcer disease, recent GI bleed, asthma, tinnitus
Adverse reactions: Bleeding
Drug interactions: Concurrent use with NSAIDs and anticoagulants increases bleeding risk.
Dose and Route: 324mg PO
Pharmacokinetics: Onset: 20 minutes
Duration: 4-6 Hours (Platelet inhibitory effects last approx 10 days)
Half Life: 3-6 Hours
Oxygen
Functional class, MOA, Indications, Contraindications, Precautions/Warnings, Adverse Reactions, Drug Interactions, Dose/Route, Pharmacokinetics
Note: Every 1L/min increase = 4% increase in concentration.
Room air = 21%, 1LPM = 25%, 2LPM = 29%
Functional Class: Oxidizer
MOA: Gas necessary for the breakdown of glucose into a usable energy form.
Indications: Presence or suspicion of hypoxia.
Contraindications: None in emergency setting.
Precautions/Warnings: Use caution with COPD pt. Monitor long-term high concentrations in neonates.
Adverse Reactions: Mouth and nasal dryness.
Drug Interactions: None
Dosage/Route: 25%-100% concentrations via BLS and ALS airway adjuncts to maintain SpO2 94%-99%
Pharmacokinetics: Onset = Immediate. Duration = 2 min from removal of source.
Albuterol ( Proventil, Ventolin)
Functional class, MOA, Indications, Contraindications, Precautions/Warnings, Adverse Reactions, Drug Interactions, Dose/Route, Pharmacokinetics
Functional Class: Sympathomimetic bronchodilator, Beta2 Agonist
MOA: Relaxes bronchiole smooth muscle, by direction action on Beta2 receptors, with little to no effect on heart rate.
Indications: Bronchospasm, reversible obstructive airway disease
Contraindications: Hypersensitivity
Precautions/Warnings: Can cause paradoxical bronchospasm. Use caution in patients with cardiovascular disease. Use caution in HYPOkalemic patients as albuterol can decrease serum potassium levels.
Adverse Reactions: Tremors, anxiety, HYPERtension, tachycardia, headache, palpitations, seizures, nausea, dizziness, rash.
Drug Interactions: Other sympathomimetic bronchodilators, beta blockers. Potentiation may occur in patients on MAOI’s and TCAs (antidepressants)
Dose/Route: Adult- 2.5 mg in 3mL 0.9% NaCl via nebulizer every 5 min as needed
Pedi- 1.25mg in 2-3mL 0.9% NaCl via nebulizer every 5 min as needed
Pharmacokinetics: Onset = 5-15 min
Duration = 2-6 hours
Half-life = 6 hours
Ipratropium Bromide (Atrovent)
Functional class, MOA, Indications, Contraindications, Precautions/Warnings, Adverse Reactions, Drug Interactions, Dose/Route, Pharmacokinetics
Note: When given in prehospital setting, ipratropium bromide is combined with albuterol to create “DuoNeb” and is not given as the sole agent.
Functional Class: Parasympatholytic bronchodilator, anticholinergic agent
MOA: Blocks action of acetylcholine at parasympathetic sites in bronchiole smooth muscle, causing bronchodilation. Inhibits serous and seromucous gland secretions.
Indications: Bronchospasm, reversible obstructive airway disease.
Contraindications: Hypersensitivity to ipratropium or atropine.
Precautions/Warnings: Can cause paradoxical bronchospasm, anaphylaxis.
Adverse Reactions: Headache, dizziness, nausea.
Drug Interactions: May infancy effects of other anticholinergic agents.
Dose/Route: Adult + Pedi (over 2 yrs) 0.5mg via nebulizer every 6 hours
Pedi (Under 2 yrs) 0.25mg via nebulizer every 6 hours
Pharmacokinetics: Onset = 20 minutes
Duration = 3-5 Hours
Half-life = 2 hours
Norepinephrine (Levophed)
Functional class, MOA, Indications, Contraindications, Precautions/Warnings, Adverse Reactions, Drug Interactions, Dose/Route, Pharmacokinetics
Functional Class: Sympathomimetic
MOA: Stimulates Beta1 and Alpha-Adrenergic receptors, causing increased contractility, increased heart rate, and vasoconstriction. This increases systemic blood pressure and coronary blood flow. Alpha effects (vasoconstriction) are greater than Beta effects (inotropic and chronograph).
Indications: HYPOtension in post-resuscitative care, sepsis, non-traumatic shock, and symptomatic bradycardia.
Contraindications: None in emergency setting.
Precautions/Warnings: Ensure adequate volume resuscitation prior to initiation of infusion. Can cause tissue necrosis with extravasation. May produce ventricular dysrhythmias in hypoxic or hypercarbic patients.
Adverse Reactions: Bradycardia, cardiac arrhythmia, cardiomyopathy, anxiety, dyspnea.
Drug Interactions: Alpha and/or Beta blockers may diminish effects. Enhances effects of Alpha and Beta agonists.
Dose/Route: 2-30 mcg/min IV/IO infusion.
Pharmacokinetics: Onset = Immediate
Duration = 1-2 minutes after infusion ends
Half-life = 1-2 minutes
Atropine (AtroPen)
Functional Class
Parasympatholytic, anticholinergic agent
Atropine (AtroPen)
MOA
Blocks action of acetylcholine at parasympathetic sites in smooth muscle, secretory glands, and the CNS.
Increased cardiac output and dries secretions.
Reverses muscarinic effects of cholinergic poisoning by acting as a competitive antagonist of acetylcholine.
Atropine (AtroPen)
Indications/Contraindications
Indications: Symptomatic bradycardia. Organophosphate poisoning.
Contraindications: None in the emergency setting.
Atropine (AtroPen)
Precautions/Warnings
May worsen bradycardia in 2nd Degree Type 2 and 3rd Degree heart blocks.
Use caution with patients with acute myocardial ischemia, infarction, and glaucoma.
Atropine (AtroPen)
Adverse Reactions
Paradoxical bradycardia (if pushed too slowly) blurred vision, dilated pupils, dry mouth, tachycardia, drowsiness, convulsions, hyper/hypotension, palpitations, AV dissociation, urinary retention.
Atropine (AtroPen)
Drug Intercations
Antihistamines, tricyclic antidepressants, and procainamide can lead to anticholinergic effects.
Atropine (AtroPen)
Dose/Route
Adult:
Symptomatic Bradycardia: 0.5mg IV/IO every 3-5 minutes up to 3mg
Organophosphate: 2mg IV/IO every 5 minutes as needed.
Pedi:
Brady: 0.02 mg/kg IV/IO (max 0.5mg)
Organophosphate: 0.05-0.1 mg/kg IV/IO/IM (min 0.1mg, max 2mg) every 2-5 as needed
Amiodarone
Functional Class
Class 3 Anti-arrhythmic, Potassium Channel Blocker
Amiodarone
MOA
Prolongs duration of action potential and refractory period by blocking potassium channels.
Exhibits some sodium and calcium channel blockage.
Inhibits adrenergic stimulations.
Amiodarone
Indications
V-Tach, V-Fib, A-Fib, A-Flutter, SVT, WPW
Amiodarone
Contraindications
Cardiogenic shock, 2nd + 3rd degree blocks, bradycardia, hypersensitivity.
Amiodarone
Precautions/Warnings
Bradycardia and HYPOtension.
Cautions in pt w/ severe liver disease due to possible hepatotoxicity.
Can exacerbate arrhythmia.
Amiodarone
Adverse reactions
HYPOtension, AV Block, Bradycardia, Hepatotoxicity, Cardiogenic shock, nausea/vomiting, phospholipidemia.
Amiodarone
Drug Interactions
Increased digoxin levels.
Increases pharmacological effects of procainamide, lidocaine, quinidine, and oral anticoagulants.
Concurrent use of calcium channel blockers, beta blockers, fentanyl, or cimetidine may potentiate bradycardia.
Amiodarone
Dose and Route
Adult;
With Pulse: 150mg in 50-100ml 0.9% NaCl IV/IO infused over 10 minutes. Repeat after 10 minutes
Pulseless: 300mg IV/IO; Repeat in 3-5 min at 150mg.
Pedi;
5mg/kg IV/IO, may repeat twice to max dose 15mg/kg.
Metoprolol (Lopressor)
Class
Class 2 Anitarrhythmic, Beta Blocker
Metoprolol (Lopressor)
MOA
Selectively inhibits Beta-1 adrenergic receptors located on cardiac muscle.
Completely blocks Beta-1 receptors with little to no effect on Beta-2 receptors (at oral dose <100mg)
Reduces heart rate, cardiac output, and blood pressure
Metoprolol (Lopressor)
Indications
Narrow complex tachycardias (>150 bpm)
Not considered a first line tx
Metoprolol (Lopressor)
Contraindications
Hypersensitivity, sinus bradycardia, 2nd and 3rd degree blocks (except in pt w/functioning artificial pacemaker), Cardiogenic shock, uncompensated cardiac failure, pregnancy, asthma, COPD
Metoprolol (Lopressor)
Precautions & Warnings
Hx of severe anaphylaxis to allergens as pt taking beta-blockers may become more sensitive.
Metoprolol (Lopressor)
Adverse reactions
HYPOtension, bradycardia, dizziness
Metoprolol (Lopressor)
Drug Interactions
Drugs that slow AV conduction (digoxin) may cumulate the effects.
May blunt the hyperglycemic action of glucagon.
May have synergistic pharmacological effects when given with calcium channel blockers
Metoprolol (Lopressor)
Dose and Route
5mg IV/IO over 2-5 min every 5 min up to 15 mg
Diltiazem (Cardizem)
Functional Class
Class 4 Antiarrhythmic, Calcium Channel Blocker
Diltiazem (Cardizem)
MOA
Inhibits calcium ions from entering “slow channels” or select voltage-sensitive areas of vascular smooth muscle and myocardium during depolarization.
Relaxes coronary vascular smooth muscle.
Produces coronary vasodilation.
Increases myocardial oxygen delivery in pt with vasospastic angina.
Diltiazem (Cardizem)
Indications
SVT refractory to Adenosine.
Rapid A-fib, A-Flutter
Diltiazem (Cardizem)
Contraindications
Hypersensitivity, sick sinus syndrome, 2nd & 3rd degree blocks, HYPOtension, WPW, Wide-complex tachycardia, cardiogenic shock.
Diltiazem (Cardizem)
Precautions/Warnings
Monitor for HYPOtension resulting from peripheral vasodilation.
Avoid use in heart failure pt.
Diltiazem (Cardizem)
Adverse Reactions
AV Block, HYPOtension, palpitations, dizziness, edema, headache.
Diltiazem (Cardizem)
Drug Interactions
Calcium-channel blockers may potentiate HYPOtension.
Diltiazem (Cardizem)
Dose and Route
Bolus: 0.25mg/kg slow IV/IO, may repeat in 15 min at 0.35mg/kg IV/IO (max single dose 20mg)
Infusion: 5-15mg/hr IV/IO, titrate to heart rate
Diltiazem (Cardizem)
Pharmacokinetics
Onset = 2-5 min
Duration = unknown
Half-Life = 3-4.5 hours
Dopamine (Intropin)
Functional Class
Sympathomimetic
Dopamine (Intropin)
MOA
Naturally occurring neurotransmitter and catecholamine
Acts on alpha and beta adrenergic receptors (dose-dependent) and dopaminergic receptors
Therapeutic doses: maintains blood flow in renal and mesenteric vascular beds
Positive inotrope (increased cardiac output and systolic b/p)
Dopamine (Intropin)
Indications
Cardiogenic shock, hemodynamically significant hypotension (70-100 not resulting from hypovolemia), symptomatic bradycardia.
Dopamine (Intropin)
Contraindications
Tachyarrhythmias, v-fib, phenochromocytoma
Dopamine (Intropin)
Precautions/Warnings
20 mcg/kg/min or greater, alpha effects dominate and causes severe vasoconstriction.
Monitor BP every 3-5 min.
Can be deactivated by sodium bicarb.
Dopamine (Intropin)
Adverse Reactions
Arrhythmias, palpitations, hypertension, dyspnea, tachycardia, bradycardia, headaches, anxiety, nausea, vomiting, tissue sloughing may result from extravasation.
Dopamine (Intropin)
Drug Interactions
Use caution with other vasoactive medications.
Dopamine (Intropin)
Dose, Route, Pharmacokinetics
2-20 mcg/kg/min IV/IO infusion. Titrate to effect blood pressure.
2-5 mcg/kg/min =Dopaminergic Effects
5-10 mcg/kg/min = Beta Effects
10-20 mcg/kg/min = Alpha Effects
Onset = 5 min
Duration = 10 min
Half-Life = 2 min
Acetaminophen (Tylenol)
Functional Class
Analgesic, non-opioid
Acetaminophen (Tylenol)
MOA
Analgesic effects believed to be due to activation of descending serotonergic inhibitory pathways (blocking pain) in the CNS. Exhibits some antipyretic properties, via the inhibition of hypothalamic heat-regulating center.
Acetaminophen (Tylenol)
Indications
Mild to moderate pain
Acetaminophen (Tylenol)
Contraindications
Hypersensitivity, severe hepatic impairment or active liver disease.
Do not use with other products containing acetaminophen.
Acetaminophen (Tylenol)
Precautions/Warnings
Has been associated with acute liver failure. Hepatotoxicity is usually associated with excessive acetaminophen intake. Use caution with alcoholics.
Acetaminophen (Tylenol)
Adverse Reactions
Nausea, vomiting, dizziness, hepatotoxicity, renal failure, HYPOglycemia.
Acetaminophen (Tylenol)
Drug Interactions
Increased chance of hepatotoxicity when taken chronically or with alcohol, rifampin, carbamazepine.
Acetaminophen (Tylenol)
Dose/Route
Adult: 325-1000mg PO/IV Q 4-6 hours
Pedi: 15mg/kg PO/PR Q 4-6 hours
Acetaminophen (Tylenol)
Pharmacokinetics
Onset: 15 min (IV) 60 min (PO)
Duration: 4-6 hours
Half-Life: 2-6 hours
Ibuprofen (Advil, Motrin)
Functional Class
Analgesic, non-opioid: NSAID
Ibuprofen (Advil, Motrin)
Mechanism
Inhibits cyclooxygenase 1 and 2 (COX-1 and 2), which results in decreased formation of prostaglandin precursors. Has antipyretic, analgesic, and anti-inflammatory properties.
Ibuprofen (Advil, Motrin)
Indications
Mild to moderate pain
Ibuprofen (Advil, Motrin)
Contraindications
Hypersensitivity, history of allergy to ASA or other NSAIDs
Ibuprofen (Advil, Motrin)
Precautions/Warnings
Anaphylactic reactions may occur even in pt without past reaction.
NSAIDs can cause increased risk of serious cardiovascular thrombotic events (MI, Stroke).
Increased risk of serious GI inflammation, ulceration, bleeding, and perforation. Elderly and pt w/ hx of peptic ulcers/GI bleed are at greater risk.
Platelet adhesion and aggregation may be decreased.
Caution in pt with liver and renal disease.
Ibuprofen (Advil, Motrin)
Adverse Reactions
Abd pain, nausea, vomiting, headaches, dizziness, reduced hemoglobin.
Ibuprofen (Advil, Motrin)
Drug Interactions
Reduces the effectiveness of loop diuretics and ACE inhibitors.
Enhances effect of other agents with anti-platelet properties.
Ibuprofen (Advil, Motrin)
Dose and Route
Adult: 400mg-800mg PO q 6-8 hours
Pedi: 10mg/kg (max single 400mg) q 6-8 hours.
Ibuprofen (Advil, Motrin)
Pharmacokinetics
Onset: 30-60 min
Duration: 4-6 hours
Half-Life: 2 hours
Hydromorphone (Dilaudid)
Functional Class
Analgesic, opioid
Hydromorphone (Dilaudid)
Mechanism of Action
Binds to opioid receptors in the CNS. Alters the reception of, and response to, pain.
Hydromorphone (Dilaudid)
Indications
Moderate to severe pain
Hydromorphone (Dilaudid)
Contraindications
Hypersensitivity
SBP <100
Hydromorphone (Dilaudid)
Precautions/Warnings
CNS depression
Severe respiratory depression
HYPOtension
Elevated ICP or suspected head injury
Hydromorphone (Dilaudid)
Adverse Reactions
Severe respiratory depression, bronchoconstriction, chest wall rigidity
Sedation, bradycardia, hypotension, cardiac arrest
Nausea, vomiting, blurred vision, miosis
Hydromorphone (Dilaudid)
Drug Interactions
Effects may increase with other CNS depressants (alcohol, narcotics, sedatives/hypnotics)
MAOI use may cause serotonin syndrome.
Hydromorphone (Dilaudid)
Dose/Route
Adult:
0.5mg - 1mg IV/IO q 10 min up to 4 mg
1mg - 2mg IM q 20 min up to 4mg
Pedi:
0.01 - 0.02mg/kg (max single 1mg) IV/IO q 10 minutes up to 4mg.
Hydromorphone (Dilaudid)
Pharmacokinetics
Onset = 1-5 min
Durations = 3-4 hrs
Half Life = 2-3 hrs
Lidocaine
Functional Class
Class 1B Anti-arrhythmic, Sodium Channel Blocker
Lidocaine
Mechanism of Action
Suppresses depolarization and automaticity of His-Purkinjie system.
Suppresses ventricular ectopy and increases ventricular threshold for arrhythmias.
May decrease ventricular threshold for defibrillation.
Lidocaine
Indications
V-Fib, V-Tach, malignant PVCs (>6 unifocal/min), multiple PVCs, couplets, R on T.
Lidocaine
Contraindications
Hypersensitivity
Adam-Stokes Syndrome
WPW
2nd or 3rd degree blocks
Lidocaine
Precautions/ Warnings
Constant EKG monitoring during IV administration.
Use caution in hepatic (liver) impairment, heart failure, and shock.
Monitor for signs of CNS toxicity.
Elderly more prone to CNS + cardiovascular side effects.
Lidocaine
Adverse Reactions
Headache, altered mental status
Arrhythmia, bradycardia, heart block
Coronary artery vasospasm
Lidocaine
Drug Interactions
Drug toxicity may result from use with beta blockers or procainamide.
Lidocaine
Dose and Route
Adult:
Ventricular Arrhythmia:
1-1.5mg/kg IV/IO.
0.50-0.75mg/kg if V-Fib/pVT persists.
Infusion: 1-4mg/min IV/IO using the “+1 rule”
Pedi:
Ventricular Arrhythmia:
1mg/kg IV/IO max dose 100mg
Lidocaine
Pharmacokinetics
Onset=45-90 sec
Duration=10-20min
Half-Life=1.5-2hrs
Hydrocortisone (Solu-Cortef)
Functional Class
Corticosteroid
Hydrocortisone (Solu-Cortef)
Mechanism of Action
Adrenocorticoid with glucocorticoid and mineralcorticcoid properties.
Weak anti-inflammatory but potent mineralcorticoid.
Potency similar to cortisone and 2x prednisone.
Drug of choice for replacement therapy in adrenal insufficiency.
Hydrocortisone (Solu-Cortef)
Indications
Chronic adrenal insufficiency pt who are critically ill/injured*
*Shock (any), fever, multi-system trauma, drowning, hyper-hypo thermos, multi long bone fx, resp distress, dehydration, burns, RSI.
Hydrocortisone (Solu-Cortef)
Contraindications
Hypersensitivity, systemic fungal infection, premi infants.
Hydrocortisone (Solu-Cortef)
Precautions/Warnings
Recent MI, GI ulcer, renal disease, HYPERtension, DM, HYPOthyroidism, cirrhosis, diverticulitis, ulcerative colitis, thromboembolic disorders, sz, myasthenia gravis, heart failure, tuberculosis.
Hydrocortisone (Solu-Cortef)
Adverse Reactions
Heart failure, arrhythmias, thromboembolism
Hydrocortisone (Solu-Cortef)
Drug Interactions
None in emergency setting
Hydrocortisone (Solu-Cortef)
Dose and Route
Adult:
100mg IV/IO
Pedi:
2mg/kg IV/IO/IM max 100mg
Hydrocortisone (Solu-Cortef)
Phamacokinetics
Onset=variable, peak 1-2hrs
Duration=variable
Half-Life= 8-12hrs
Methylprednisolone (Solu-Medrol)
Functional Class
Corticosteroid
Methylprednisolone (Solu-Medrol)
Mechanism of Action
Intermediate-acting synthetic adrenal corticosteroid.
Decreases inflammation by reversing increased capillary permeability. This suppresses the migration of leukocytes and fibroblasts to site of injury.
Stabilizes lysosomes.
Methylprednisolone (Solu-Medrol)
Indications
Asthma/COPD exacerbation
Anaphylaxis
Methylprednisolone (Solu-Medrol)
Contraindications
None in management of anaphylaxis.
Methylprednisolone (Solu-Medrol)
Precautions/Warnings
CHF, Tuberculosis, and Peptic ulcer disease.
Methylprednisolone (Solu-Medrol)
Adverse Reactions
HTN, CHF, HYPERglycemia, circulatory collapse, nausea, vomiting, headache, HYPOkalemia, CNS depression, delayed wound healing.
Methylprednisolone (Solu-Medrol)
Drug Interactions
Caution in pt on salicylates (ASA), phenytoin (Dilantin; Seizures), rifampin (TB), theophylline (Bronchodilator), furosemide (Lasix), and thiazide diuretics (HCTZ)
Methylprednisolone (Solu-Medrol)
Dose & Route
Adult:
125mg IV/IO
Pedi:
2mg/kg IV/IO max dose 125mg
Methylprednisolone (Solu-Medrol)
Pharmacokinetics
Onset = Rapid
Duration = 7 Days
Half-Life = 2-3 Hours
Magnesium Sulfate
Functional Class
Electrolyte
Magnesium Sulfate
Mechanism of Action
Torsades: Decreases acetylcholine in motor nerve terminals. Acts on myocardium by slowing rate of SA node impulse formation which prolongs conduction time. Mag is necessary for movement of calcium and potassium in and out of cell walls as well as stabilizing excitable membranes.
Asthma: Improves pulmonary function by causing bronchial smooth muscle relaxation.
Eclampsia: Thought to trigger cerebral vasodilation, reducing ischemia generated by cerebral vasospasm during eclampsia events. Competitively blocks the entry of calcium into the synaptic ending, altering neuromuscular transmission.
Magnesium Sulfate
Indications
Eclampsia, Torsade de Pointes, asthma exacerbation.
Magnesium Sulfate
Contraindications
Heart block, shock, HYPOcalcemia, myocardial damage.
Magnesium Sulfate
Precautions
Use extreme caution in patients with neuromuscular disease and renal impairment.
Magnesium Sulfate
Adverse Reactions
Can have adverse effects on neuromuscular function in patients with neuromuscular disease (myasthenia gravis).
HYPOtension, vasodilation, HYPERmagnesemia
Magnesium Sulfate
Drug Interaction
Can cause cardiac conduction abnormalities when used with digitalis. May enhance CNS depressant effects of other CNS depressants.
Magnesium Sulfate
Dose and Route
Eclampsia: 4g IV/IO (in 100mL 0.9% NaCl) bolus over 10 minutes; consider 1g/hr continuous infusion.
Torsades: 1-2g IV/IO over 5 min
Asthma: 2g IV/IO (in 100mL 0.9% NaCl) bolus over 10 minutes.
Magnesium Sulfate
Pharmacokinetics
Onset = Immediate
Duration = 30 min
Half-Life = 20 hours
Dexamethasone (Decadron)
Functional Class
Corticosteroid
Dexamethasone (Decadron)
Mechanism of Action
Has anti-inflammatory and immunosuppressive properties 30x higher than cortisol.
Inhibits inflammatory cells and suppresses expression of inflammatory mediators.
Works rapidly, within minutes, which makes it a good option for severe exacerbations.